Top Markets
Coin of the day
Pharmanutra S.p.A. Pharmanutra S.p.A.

Pharmanutra S.p.A.

PHN
Rang in Aktien #9895
Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise,... Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.
Aktienkurs
$97.03
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$929.06M
Veränderung (1 Tag)
-0.12%
Veränderung (1 Jahr)
70.33%
Land
IT
Handel Pharmanutra S.p.A. (PHN)

Kategorie

Kursverlauf für Pharmanutra S.p.A. (PHN)
Höchster Schlusskurs: $98.04 am 2026-08-01

Niedrigster Schlusskurs: $15.45 am 2017-07-01
Kursverlauf der Aktie von Pharmanutra S.p.A. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 25.47%
2025 11.38%
2024 -5.90%
2023 -8.56%
2022 -20.09%
2021 94.88%
2020 71.55%
2019 41.28%
2018 16.53%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN